Ergang Liu

1.4k total citations
44 papers, 1.1k citations indexed

About

Ergang Liu is a scholar working on Molecular Biology, Biomaterials and Immunology. According to data from OpenAlex, Ergang Liu has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Biomaterials and 9 papers in Immunology. Recurrent topics in Ergang Liu's work include RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Ergang Liu is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Ergang Liu collaborates with scholars based in China, United States and South Korea. Ergang Liu's co-authors include Yongzhuo Huang, Victor C. Yang, Huining He, Junxiao Ye, Junbo Gong, Qiuling Liang, Yanna Cui, Meong Cheol Shin, Lu Sun and Meng Zhang and has published in prestigious journals such as Advanced Functional Materials, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Ergang Liu

42 papers receiving 1.1k citations

Peers

Ergang Liu

BIOMA

IMMUN

Juliette Vergnaud France

Zongguang Tai China

Alireza Nomani Iran

Dalit Landesman‐Milo Israel

Cristina Fornaguera Spain

Kristin H. Loomis United States

Zhirong Zhong China

Ava M. Vargason United States

Mengnan Zhao China

Vijay Sagar Madamsetty United States

Juliette Vergnaud France

Ergang Liu

676 ×1.3

364 ×1.2

BIOMA

312 ×1.2

150 ×0.9

IMMUN

116 ×0.8

Citations per year, relative to Ergang Liu Ergang Liu (= 1×) peers Juliette Vergnaud

Countries citing papers authored by Ergang Liu

Since Specialization

Citations

This map shows the geographic impact of Ergang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ergang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ergang Liu more than expected).

Fields of papers citing papers by Ergang Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ergang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ergang Liu. The network helps show where Ergang Liu may publish in the future.

Co-authorship network of co-authors of Ergang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ergang Liu. A scholar is included among the top collaborators of Ergang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ergang Liu. Ergang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Qing, Fang Wang, Zhe Sun, et al.. (2025). Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery. Acta Pharmaceutica Sinica B. 15(6). 3226–3242. 4 indexed citations

Zhang, Xiaoru, Qin Liu, Han Liu, et al.. (2025). Multi-functional nanozyme-integrated astragalus polysaccharide hydrogel for targeted phased therapy in diabetic wound healing. Nano Today. 62. 102739–102739. 9 indexed citations

Li, Zeyu, Huan Shen, Quangang Xu, et al.. (2025). Colon-targeted pellets encapsulating patchouli oil cocrystal for inflammatory bowel disease treatment. Chinese Chemical Letters. 37(5). 111292–111292.

Liu, Lin, et al.. (2025). Nanobody-based drug delivery systems for cancer therapy. Journal of Controlled Release. 381. 113562–113562. 10 indexed citations

Zhang, Yangyang, et al.. (2024). Biomimetically engineered plant-derived exosomes-like nanovesicles for rheumatoid arthritis therapy. Chinese Chemical Letters. 36(9). 110658–110658. 1 indexed citations

Gao, Nan, Yiran Huang, Ergang Liu, et al.. (2024). Environment-responsive dendrobium polysaccharide hydrogel embedding manganese microsphere as a post-operative adjuvant to boost cascaded immune cycle against melanoma. Theranostics. 14(10). 3810–3826. 10 indexed citations

Shen, Huan, et al.. (2024). Asiatic acid cyclodextrin inclusion micro-cocrystal for insoluble drug delivery and acute lung injury therapy enhancement. Journal of Nanobiotechnology. 22(1). 119–119. 8 indexed citations

Liu, Ergang, Yuefei Fang, Nan Gao, et al.. (2024). Naturally sourced amphiphilic peptides as paclitaxel vehicles for breast cancer treatment. Biomaterials Advances. 159. 213824–213824. 7 indexed citations

Ye, Junxiao, Hui Cui, Ergang Liu, et al.. (2024). Temperature switchable linkers suitable for triggered drug release in cancer thermo-chemotherapy. International Journal of Pharmaceutics. 666. 124757–124757. 1 indexed citations

10.

Zhang, Meng, Ergang Liu, Guihua Chen, et al.. (2023). Recombinant cell-penetrating trichosanthin synergizes anti-PD-1 therapy in colorectal tumor. International Journal of Biological Sciences. 19(6). 1698–1712. 6 indexed citations

11.

Liu, Ergang, Meng Zhang, Feng Zeng, et al.. (2023). Oral pectin/oligochitosan microspheres for colon-specific controlled release of quercetin to treat inflammatory bowel disease. Carbohydrate Polymers. 316. 121025–121025. 36 indexed citations

12.

Fang, Yuefei, Meng Zhang, Zeyun Gu, et al.. (2021). Magnetism-mediated targeting hyperthermia-immunotherapy in “cold” tumor with CSF1R inhibitor. Theranostics. 11(14). 6860–6872. 53 indexed citations

13.

Shen, Huan, Changquan Calvin Sun, Lichun Kang, et al.. (2020). Low-dose salinomycin inhibits breast cancer metastasis by repolarizing tumor hijacked macrophages toward the M1 phenotype. European Journal of Pharmaceutical Sciences. 157. 105629–105629. 17 indexed citations

14.

Wang, Dekun, Min Xiong, Chuan’ai Chen, et al.. (2018). Legumain, an asparaginyl endopeptidase, mediates the effect of M2 macrophages on attenuating renal interstitial fibrosis in obstructive nephropathy. Kidney International. 94(1). 91–101. 46 indexed citations

15.

Liu, Ergang, Meng Zhang, Hui Cui, et al.. (2018). Tat-functionalized Ag-Fe3O4 nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery. Acta Pharmaceutica Sinica B. 8(6). 956–968. 41 indexed citations

16.

Guo, Chunlei, Yuzhi Shi, Ergang Liu, et al.. (2017). A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery. International Journal of Pharmaceutics. 533(1). 73–83. 20 indexed citations

17.

Ye, Junxiao, Ergang Liu, Junbo Gong, et al.. (2017). High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA. Theranostics. 7(9). 2495–2508. 42 indexed citations

18.

Lin, Tingting, Ergang Liu, Huining He, et al.. (2016). Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides. Acta Pharmaceutica Sinica B. 6(4). 352–358. 67 indexed citations

19.

Liu, Ergang, Jianyong Sheng, Junxiao Ye, et al.. (2014). CPP Mediated Insulin Delivery: Current Status and Promising Future. Current Pharmaceutical Biotechnology. 15(3). 240–255. 6 indexed citations

20.

He, Huining, Junxiao Ye, Ergang Liu, et al.. (2014). Low molecular weight protamine (LMWP): A nontoxic protamine substitute and an effective cell-penetrating peptide. Journal of Controlled Release. 193. 63–73. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact